• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏膜相关恒定T细胞肿瘤浸润可预测胆管癌的长期生存。

Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma.

作者信息

Zimmer Christine L, Filipovic Iva, Cornillet Martin, O'Rourke Colm J, Berglin Lena, Jansson Hannes, Sun Dan, Strauss Otto, Hertwig Laura, Johansson Helene, von Seth Erik, Sparrelid Ernesto, Dias Joana, Glaumann Hans, Melum Espen, Ellis Ewa C, Sandberg Johan K, Andersen Jesper B, Bergquist Annika, Björkström Niklas K

机构信息

Center for Infectious Medicine, Department of Medicine HuddingeKarolinska Institutet, Karolinska University HospitalStockholmSweden.

Biotech Research and Innovation Centre (BRIC)Department of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark.

出版信息

Hepatology. 2022 May;75(5):1154-1168. doi: 10.1002/hep.32222. Epub 2021 Dec 22.

DOI:10.1002/hep.32222
PMID:34719787
Abstract

BACKGROUND AND AIMS

Cholangiocarcinoma (CCA) is a malignancy arising from biliary epithelial cells of intra- and extrahepatic bile ducts with dismal prognosis and few nonsurgical treatments available. Despite recent success in the immunotherapy-based treatment of many tumor types, this has not been successfully translated to CCA. Mucosal-associated invariant T (MAIT) cells are cytotoxic innate-like T cells highly enriched in the human liver, where they are located in close proximity to the biliary epithelium. Here, we aimed to comprehensively characterize MAIT cells in intrahepatic (iCCA) and perihilar CCA (pCCA).

APPROACH AND RESULTS

Liver tissue from patients with CCA was used to study immune cells, including MAIT cells, in tumor-affected and surrounding tissue by immunohistochemistry, RNA-sequencing, and multicolor flow cytometry. The iCCA and pCCA tumor microenvironment was characterized by the presence of both cytotoxic T cells and high numbers of regulatory T cells. In contrast, MAIT cells were heterogenously lost from tumors compared to the surrounding liver tissue. This loss possibly occurred in response to increased bacterial burden within tumors. The residual intratumoral MAIT cell population exhibited phenotypic and transcriptomic alterations, but a preserved receptor repertoire for interaction with tumor cells. Finally, the high presence of MAIT cells in livers of iCCA patients predicted long-term survival in two independent cohorts and was associated with a favorable antitumor immune signature.

CONCLUSIONS

MAIT cell tumor infiltration associates with favorable immunological fitness and predicts survival in CCA.

摘要

背景与目的

胆管癌(CCA)是一种起源于肝内和肝外胆管上皮细胞的恶性肿瘤,预后不佳且可用的非手术治疗方法很少。尽管近年来基于免疫疗法在许多肿瘤类型的治疗中取得了成功,但这尚未成功应用于CCA。黏膜相关恒定T(MAIT)细胞是细胞毒性固有样T细胞,在人类肝脏中高度富集,它们紧邻胆管上皮。在此,我们旨在全面表征肝内胆管癌(iCCA)和肝门周围胆管癌(pCCA)中的MAIT细胞。

方法与结果

利用CCA患者的肝组织,通过免疫组织化学、RNA测序和多色流式细胞术研究肿瘤受累组织和周围组织中的免疫细胞,包括MAIT细胞。iCCA和pCCA肿瘤微环境的特征是存在细胞毒性T细胞和大量调节性T细胞。相比之下,与周围肝组织相比,肿瘤中的MAIT细胞异质性缺失。这种缺失可能是对肿瘤内细菌负荷增加的反应。肿瘤内残留的MAIT细胞群体表现出表型和转录组改变,但保留了与肿瘤细胞相互作用的受体库。最后,iCCA患者肝脏中MAIT细胞的高存在预示着两个独立队列中的长期生存,并与良好的抗肿瘤免疫特征相关。

结论

MAIT细胞肿瘤浸润与良好的免疫适应性相关,并可预测CCA患者的生存。

相似文献

1
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma.黏膜相关恒定T细胞肿瘤浸润可预测胆管癌的长期生存。
Hepatology. 2022 May;75(5):1154-1168. doi: 10.1002/hep.32222. Epub 2021 Dec 22.
2
Cholangiocarcinoma miscoding in hepatobiliary centres.肝胆中心胆管癌错配。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):635-639. doi: 10.1016/j.ejso.2020.09.039. Epub 2020 Oct 1.
3
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.肝内胆管癌的多模态单细胞分析将高激活的调节性T细胞定义为潜在治疗靶点。
J Hepatol. 2022 Nov;77(5):1359-1372. doi: 10.1016/j.jhep.2022.05.043. Epub 2022 Jun 20.
4
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.肝内和肝外胆管癌的危险因素:系统评价和荟萃分析。
J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16.
5
Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.揭示坏死性凋亡微环境的作用:FCGBP+肿瘤相关巨噬细胞驱动原发性肝癌向胆管细胞型肝细胞癌或肝内胆管癌分化。
Apoptosis. 2024 Apr;29(3-4):460-481. doi: 10.1007/s10495-023-01908-3. Epub 2023 Nov 28.
6
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.胆管癌的临床治疗:最新综合综述。
Ann Hepatol. 2022 Sep-Oct;27(5):100737. doi: 10.1016/j.aohep.2022.100737. Epub 2022 Jul 7.
7
Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.暴露于细菌的胆管上皮细胞和肝脏B细胞通过MR1激活肝内MAIT细胞。
J Hepatol. 2016 May;64(5):1118-1127. doi: 10.1016/j.jhep.2015.12.017. Epub 2015 Dec 29.
8
Clinical presentation, diagnosis and staging of cholangiocarcinoma.胆管癌的临床表现、诊断和分期。
Liver Int. 2019 May;39 Suppl 1:98-107. doi: 10.1111/liv.14086. Epub 2019 Mar 25.
9
Dense GM-CSFR-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients.高表达 GM-CSFR 的免疫浸润与肝内胆管癌患者的生存时间延长相关。
PeerJ. 2023 Mar 2;11:e14883. doi: 10.7717/peerj.14883. eCollection 2023.
10
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).肿瘤免疫微环境与胆管癌的当前免疫治疗(综述)。
Int J Oncol. 2023 Dec;63(6). doi: 10.3892/ijo.2023.5585. Epub 2023 Oct 27.

引用本文的文献

1
A multi-algorithm prognostic model combining inflammatory indices and surgical features in distal cholangiocarcinoma.一种结合炎症指标和手术特征的远端胆管癌多算法预后模型。
Front Oncol. 2025 Jul 21;15:1625703. doi: 10.3389/fonc.2025.1625703. eCollection 2025.
2
Research progress of T cells in cholangiocarcinoma.胆管癌中T细胞的研究进展
Front Immunol. 2025 Feb 25;16:1453344. doi: 10.3389/fimmu.2025.1453344. eCollection 2025.
3
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
4
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints.胆管癌中的浸润性T淋巴细胞与肿瘤微环境:免疫异质性、细胞间通讯、免疫检查点
Front Immunol. 2025 Jan 8;15:1482291. doi: 10.3389/fimmu.2024.1482291. eCollection 2024.
5
Tissue-resident immune cells: from defining characteristics to roles in diseases.组织驻留免疫细胞:从定义特征到在疾病中的作用
Signal Transduct Target Ther. 2025 Jan 17;10(1):12. doi: 10.1038/s41392-024-02050-5.
6
Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.治疗胆管癌冷肿瘤的策略:核心概念和未来方向。
Clin Exp Med. 2024 Aug 14;24(1):193. doi: 10.1007/s10238-024-01460-7.
7
Macrophages Orchestrate the Liver Tumor Microenvironment.巨噬细胞调控肝脏肿瘤微环境。
Cancers (Basel). 2024 May 4;16(9):1772. doi: 10.3390/cancers16091772.
8
Identification of clinically relevant subsets CD39PD-1CD8 T cells and CD39 regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF.使用单细胞质谱流式细胞术鉴定肝内胆管癌中临床相关的亚群CD39⁺PD-1⁺CD8⁺ T细胞和CD39⁺调节性T细胞
Transl Oncol. 2024 Jun;44:101954. doi: 10.1016/j.tranon.2024.101954. Epub 2024 Apr 11.
9
Phenotype and function of MAIT cells in patients with alveolar echinococcosis.泡型包虫病患者 MAIT 细胞的表型和功能。
Front Immunol. 2024 Mar 14;15:1343567. doi: 10.3389/fimmu.2024.1343567. eCollection 2024.
10
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.肿瘤相关巨噬细胞在 HCC 侵袭边缘触发 MAIT 细胞功能障碍。
Cell. 2023 Aug 17;186(17):3686-3705.e32. doi: 10.1016/j.cell.2023.07.026.